| Stage | EOG | % of rev | REPX | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $8.6B | 100.00% | $166M | 100.00% | EOG ×51.62 |
| Gross profit | $7.4B | 86.65% | $136M | 82.25% | EOG +4.4pp |
| Operating income | $3.5B | 41.21% | $87M | 52.60% | REPX +11.4pp |
| Pre-tax income | $3.5B | 40.87% | $115M | 69.16% | REPX +28.3pp |
| Net income | $2.7B | 31.81% | $87M | 52.68% | REPX +20.9pp |
| Stage | EOG | REPX | Gap · A − B |
|---|---|---|---|
| Revenue | $8.6B100.00% | $166M100.00% | EOG ×51.62 |
| Gross profit | 86.65%$7.4B | 82.25%$136M | EOG +4.4pp |
| Operating income | 41.21%$3.5B | 52.60%$87M | REPX +11.4pp |
| Pre-tax income | 40.87%$3.5B | 69.16%$115M | REPX +28.3pp |
| Net income |
| 31.81%$2.7B |
| 52.68%$87M |
| REPX +20.9pp |
No shared counterparties.